Asthmatics could breathe easier in the future with help from an unlikely quarter—parasitic hookworms

October 26, 2016, James Cook University
A hookworm infecting the body and secreting proteins in the gut, which are thought to bolster the immune system against allergies. Credit: Carla Schaffer

Asthmatics could breathe easier in the future with help from an unlikely quarter—parasitic hookworms.

Australian Institute of Tropical Health and Medicine (AITHM) researchers, at James Cook University (JCU) in Cairns, Australia, have identified a protein secreted by hookworms that suppresses asthma in mice.

In vitro tests on cells from people with asthma indicate the protein is also a promising candidate as a treatment for humans with allergies such as asthma.

This work builds on previous AITHM research into possible treatments for (IBD), including clinical trials that established experimental hookworm infection as an effective anti-inflammatory treatment for people with coeliac disease.

"After our initial success with IBD, asthma was our next logical goal," JCU immunologist Dr Severine Navarro said.

"Although IBD and asthma are very different conditions, what they have in common is a defect in the regulation of the immune system, which results in overwhelming inflammatory processes.

"To survive and remain undetected in the human gut, parasitic worms regulate their human host's immune response. We aim to use that to control the inappropriate inflammation that characterizes autoimmune diseases and allergy," Dr Navarro said.

The asthma study, published today in Science Translational Medicine, tested a recombinant form of the protein on both mice and human cells. Mice treated with the worm protein showed an extensive suppression of inflammatory responses after exposure to an allergen.

The protein, AIP-2, was also tested in vitro on human cells - from people allergic to dust mites, a common asthma trigger.

"Our previous work on inflammatory bowel disease established that hookworm proteins can change T cells from pro-inflammatory to anti-inflammatory," Dr Navarro said. "The good news is that this doesn't just protect the gut, it also protects other organs, such as the airways, where asthma develops."

Professor Alex Loukas, head of JCU's Centre for Biodiscovery and Molecular Development of Therapeutics, said AIP-2 showed great promise as a potential treatment for allergies, which affect nearly a billion people worldwide, costing over $9 billion per year in Australia alone.

"This study also represents an important step forward in our exploitation of the therapeutic potential of hookworm proteins," Professor Loukas said.

"In our initial work on IBD we infected some very committed trial participants with actual hookworms. We have since established that the protective properties of hookworms lie in their oral secretions. More recently, we've isolated AIP-2, one of the most abundant proteins in that secretion mixture.

"In the asthma study, we used a recombinant form of AIP-2, which is to say we're now able to reproduce it in large quantities. We treated the mice with it by injection and also intranasal.

"This is an exciting development for us, because it means we're another step closer to being able to put a pill-based treatment into clinical trials, not just for but also for other inflammatory and ."

Explore further: Working towards a worm protein pill for inflammatory disease

More information: "Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma," Science Translational Medicine, … scitranslmed.aaf8807

Related Stories

Working towards a worm protein pill for inflammatory disease

October 28, 2014
Australian scientists who have successfully regulated the inflammatory response in coeliac patients by infecting them with hookworms are now collaborating with a major pharmaceutical company to develop a treatment for inflammatory ...

Spaghetti for celiac patients? Just add worms

September 25, 2014
Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease.

Strategy for depleting immune cells implicated in asthma-associated inflammation

May 19, 2016
Patients with asthma have chronic lung inflammation that results in sporadic narrowing of the airways and difficulty breathing. Symptoms and severity are variable among individuals; however, the cells and inflammatory factors ...

Asthma in many adolescents is not an allergic disease

January 13, 2016
New research indicates that asthma in many adolescents is not likely to involve inflammation of the airways and therefore should not be considered an allergic disease.

Study identifies new target for severe asthma, chronic inflammatory diseases

February 10, 2016
Platelets, the colorless blood cells responsible for clotting, play a critical role in controlling inflammation, but their effect on the immune system is less clear. A new Yale-led study has identified a protein from platelets—Dkk-1—that ...

Discovery could lead to better asthma treatment

April 21, 2016
Scientists have made a discovery that could lead to improved treatment for asthma sufferers.

Recommended for you

Quintupling inhaler medication may not prevent asthma attacks in children

March 19, 2018
Children with mild to moderate asthma do not benefit from a common practice of increasing their inhaled steroids at the first signs of an asthma exacerbation, according to clinical trial results published in The New England ...

How allergens trigger asthma attacks

March 19, 2018
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma ...

Single steroid-bronchodilator treatment for control and rescue improves persistent asthma

March 19, 2018
When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is ...

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...

Immune system 'double agent' could be new ally in cancer fight

March 16, 2018
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...

Artificial sweetener Splenda could intensify symptoms in those with Crohn's disease

March 15, 2018
In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.